Literature DB >> 8608618

Right ventricular diastolic dysfunction in heart failure.

C M Yu1, J E Sanderson, S Chan, L Yeung, Y T Hung, K S Woo.   

Abstract

BACKGROUND: Left ventricular (LV) diastolic dysfunction is common in heart failure and is an important predictor of prognosis and mortality. Less attention has been paid to right ventricular (RV) diastolic function. In this study, we compared RV diastolic function in a large cohort of patients with heart failure (HF) with two groups: patients with pulmonary hypertension and normal LV function (the PHT group) and normal subjects. METHODS AND
RESULTS: Transtricuspid and pulmonary artery flow were assessed by two-dimensional Doppler echocardiography at maximum inspiration and expiration in 185 subjects: 114 symptomatic HF patients (ejection fraction < 0.5), 31 PHT patients (pulmonary artery systolic pressure > 40 mm Hg), and 40 normal subjects. A subset was matched for age and heart rate. The results showed a high prevalence of RV diastolic abnormalities: HF patients had lower tricuspid E-A ratios, lower peak E-wave velocity, and prolonged RV isovolumic relaxation time (all P< .0001). Tricuspid E-wave deceleration time was significantly shorter only in those who had an LV restrictive filling pattern. The PHT group had similar findings. Compared with a normal range, more than half of the patients had lower tricuspid E-A ratios (HF, 55%; PHT, 69%), and 61% of HF and 58% of PHT patients had a prolonged RV isovolumic relaxation time. In the PHT group, RV diastolic parameters (E-wave deceleration time, E-A ratio, and isovolumic relaxation time) correlated significantly with pulmonary artery systolic pressure (P< .05). In the HF group, however, only tricuspid E-wave deceleration time correlated significantly with pulmonary artery systolic pressure, and HF patients with normal pulmonary artery systolic pressures had significantly lower tricuspid E-A ratios and prolonged RV isovolumic relaxation times compared with normal subjects. A close correlation existed between individual RV and LV diastolic parameters, suggesting that LV diastolic dysfunction may directly affect RV function, but there was no relation between LV size or systolic function and RV diastolic dysfunction.
CONCLUSIONS: RV diastolic function is frequently abnormal in HF patients, and this is not related to elevated pulmonary artery systolic pressure alone, although high pulmonary artery pressure by itself also is associated with impaired RV diastolic function. Assessment of the role of right ventricular diastolic function in determining the symptoms and prognosis of heart failure is warranted.

Entities:  

Mesh:

Year:  1996        PMID: 8608618     DOI: 10.1161/01.cir.93.8.1509

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Validity of the right ventricular Doppler index for assessment of severity of congestive heart failure in patients with dilated cardiomyopathy.

Authors:  C Izumi; S Kibira; H Watanabe; M Nakagawa; S Wen; H Fujii; T Saito; H Matsuoka; M Miura
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction.

Authors:  R Kaprielian; A D Wickenden; Z Kassiri; T G Parker; P P Liu; P H Backx
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

3.  Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary artery stenosis.

Authors:  H B Grotenhuis; L J M Kroft; S G C van Elderen; J J M Westenberg; J Doornbos; M G Hazekamp; H W Vliegen; J Ottenkamp; A de Roos
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

4.  Watching the right ventricle in treated congenital heart disease.

Authors:  Thomas L Gentles
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

5.  New observations from MR velocity-encoded flow measurements concerning diastolic function in constrictive pericarditis.

Authors:  Kerstin Bauner; A Horng; Ch Schmitz; M Reiser; A Huber
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

6.  The role of elastic restoring forces in right-ventricular filling.

Authors:  Candelas Pérez Del Villar; Javier Bermejo; Daniel Rodríguez-Pérez; Pablo Martínez-Legazpi; Yolanda Benito; J Carlos Antoranz; M Mar Desco; Juan E Ortuño; Alicia Barrio; Teresa Mombiela; Raquel Yotti; Maria J Ledesma-Carbayo; Juan C Del Álamo; Francisco Fernández-Avilés
Journal:  Cardiovasc Res       Date:  2015-02-17       Impact factor: 10.787

7.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

8.  Right atrial-right ventricular coupling in heart failure with preserved ejection fraction.

Authors:  Maximilian von Roeder; Johannes Tammo Kowallick; Karl-Philipp Rommel; Stephan Blazek; Christian Besler; Karl Fengler; Joachim Lotz; Gerd Hasenfuß; Christian Lücke; Matthias Gutberlet; Holger Thiele; Andreas Schuster; Philipp Lurz
Journal:  Clin Res Cardiol       Date:  2019-05-03       Impact factor: 5.460

9.  The relationship between heart rate recovery and brain natruretic Peptide in patients with chest discomfort: a study for relationship between heart rate recovery and pre-exercise, post-exercise levels of brain natruretic Peptide in patients with normal systolic function and chest discomfort.

Authors:  Jae Eun Lee; Bum Soo Kim; Wan Park; Jung Kwon Huh; Byung Jin Kim; Ki Chul Sung; Jin Ho Kang; Man Ho Lee; Jung Ro Park
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

10.  Three-wall segment (TriSeg) model describing mechanics and hemodynamics of ventricular interaction.

Authors:  Joost Lumens; Tammo Delhaas; Borut Kirn; Theo Arts
Journal:  Ann Biomed Eng       Date:  2009-08-29       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.